The effect op corticosteroids on quality of life following total hip arthroplasty: HIPSTER study

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-524368-39-00

Enrollment

224

Registered

2026-01-21

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients aged 60 years or older undergoing total hip arthroplasty

Brief summary

Health-related quality of life (EQ-5D-5L) on day 30, 60 and 90 following surgery

Detailed description

Quality of recovery (QoR-15) on day 1, day 3, and day 5 following surgery, Health-related quality of life (EQ-VAS) on day 30, 60 and 90 following surgery, Oxford Hip Score (OHS) on day 30, 60 and 90 following surgery, Brief Pain Inventory (BPI) on day 30, 60 and 90 following surgery, Chalder fatigue questionnaire (CFQ) on day 30, 60 and 90 following surgery

Interventions

DRUGAacidexam 5 mg/ml solution injectable

DRUGAacidexam 5 mg/ml oplossing voor injectie

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Health-related quality of life (EQ-5D-5L) on day 30, 60 and 90 following surgery	—

Secondary

Measure	Time frame
Quality of recovery (QoR-15) on day 1, day 3, and day 5 following surgery, Health-related quality of life (EQ-VAS) on day 30, 60 and 90 following surgery, Oxford Hip Score (OHS) on day 30, 60 and 90 following surgery, Brief Pain Inventory (BPI) on day 30, 60 and 90 following surgery, Chalder fatigue questionnaire (CFQ) on day 30, 60 and 90 following surgery	—

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026